Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-05-26 00:00:00 ET · period of report 2022-05-24 · accession 0001567619-22-011800 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-26 | 2022-05-24 | BMRN | PYOTT DAVID E I | Dir | A - Grant | $0.00 | +4,980 | 40.8K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-24 | A | A | 4,980 | $0.00 | 40,840 | D | — | — | (F1) Restricted stock units granted on May 24, 2022. Price not applicable. |